electroCore,

electroCore, EPS

The Earnings per Share (EPS) of electroCore, (ECOR) as of Oct 17, 2026 is -1.74 USD. In the previous year, Earnings per Share (EPS) was -1.59 USD — a change of 9.85% (lower).

EPS

-1.74USD

YoY

9.85%

Last updated:

Earnings per Share (EPS) of electroCore, is 2025 -1.74 USD. Earnings per Share (EPS) of electroCore, was 2024 -1.59 USD. It decreases by 9.85% lower compared to the previous year.

The electroCore, EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2023
-2.85 USD
Jan 1, 2024
-1.59 USD
Jan 1, 2025
-1.74 USD
Jan 1, 2026 (e)
-1.38 USD
Jan 1, 2027 (e)
-0.62 USD
Jan 1, 2028 (e)
0.18 USD
Jan 1, 2029 (e)
0.15 USD
Jan 1, 2030 (e)
0.65 USD
The electroCore, EPS history
YEAREPSYoY
est0.65USD+333.33%
est0.15USD-16.67%
est0.18USD-128.92%
est-0.62USD-54.76%
est-1.38USD-21.14%
-1.74USD+9.85%
-1.59USD-44.20%
-2.85USD-39.06%
-4.67USD+27.81%
-3.66USD-52.95%
-7.77USD-66.09%
-22.91USD-19.78%
-28.56USD+416.91%
-5.52USD+251.07%
-1.57USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Earnings per Share (EPS) of electroCore, is -1.74 USD in 2025.

Earnings per Share (EPS) of electroCore, changed from -1.59 USD to -1.74 USD, representing a 9.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) electroCore, since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — electroCore,

All Key Metrics — electroCore,